Skip to main content
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2001 Mar-Apr;16(2):77–81. doi: 10.1177/153331750101600207

Apolopoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease

Turgay Isbir, Bedia Agaçhan, Hülya Yilmaz, Makbule Aydin, Ihsan Kara 1, Engin Eker, Deniz Eker 2
PMCID: PMC10833945  PMID: 11302074

Abstract

In this study, the relationship between lipid profiles of sera and apolipoprotein E (apo E) gene polymorphism was investigated in 35 patients with Alzheimer's disease (AD) and 29 healthy people.

Apo E genotypes and allele frequencies of the AD patient group were: apo E2/3, 2 (5.7 percent); apo E2/4, 1 (2.9 percent); apo E3/3, 26 (74.3 percent); apo E3/4, 5 (14.3 percent); apo E4/4, 1 (2.9 percent); 2, 3(4.2 percent); 3, 59 (84.2 percent); 4, 8 (11.4 percent). The healthy group's apo E genotypes and allele frequencies were: apo E2/3, 1 (3.4 percent); apo E3/3, 27 (93.1 percent); apo E3/4, 1 (3.4 percent); 2, 1 (1.7 percent); 3, 56 (96.5 percent); 4, 1 (1.7 percent). In Alzheimer's cases, 4 allele frequencies increased significantly as compared to the healthy group (p < 0.05). When the effects of the apo E isoforms on lipid profiles were evaluated, a relationship between apo E 4 allele and high total levels of serum cholesterol was found, whereas of apo E 2 allele was associated with the low total cholesterol of serum, although the difference was not statistically significant (p > 0.05).

This study confirms the association of apo E 4 allele with lipid profiles in AD patients.

Keywords: allele, Alzheimer's disease(AD), apolipoprotein E (apo E), genetics, lipid profiles, plaques, polymorphism, tangles

Full Text

The Full Text of this article is available as a PDF (95.4 KB).

Contributor Information

Ihsan Kara, Institute of Experimental Medical Research, Department of Molecular Medicine, University of Istanbul, Istanbul, Turkey.

Deniz Eker, Department of Neurogeriatrics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey.

References

  1. Saunders AM , Strittmatter WJ, Schmechel D, et al.: Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993; 43: 1467-1472. [DOI] [PubMed] [Google Scholar]
  2. Corder EH , Saunders AM, Strittmatter WJ, et al.: Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in lateonset families. Science. 1993; 261: 921-923. [DOI] [PubMed] [Google Scholar]
  3. Saunders AM, Strittmatter WJ, Schmechel D, et al.: op. cit.
  4. Weisgraber KH , Pitas RE, Mahley RW: Lipoproteins, neurobiology, and Alzheimer's disease: Structure and function of apolipoprotein E. Curr Opin Struct Biol. 1994; 4: 507-515. [Google Scholar]
  5. Weisgraber KH , Roses AD, Strittmatter WJ: The role of apolipoprotein E in the nervous system. Curr Opin Lipidol. 1994; 5: 110-116. [DOI] [PubMed] [Google Scholar]
  6. Davignon J , Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8: 1-21. [DOI] [PubMed] [Google Scholar]
  7. Mahley RW : Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science. 1988; 240: 622-630. [DOI] [PubMed] [Google Scholar]
  8. Boyles JK , Zoellner CD, Anderson LJ, et al.: A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and miyelination of the rat sciatic nerve. J Clin Invest. 1989; 83: 1015-1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Basu SK , Ho YK, Brown MS, et al.: Genetic studies of apolipoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem. 1982; 257: 9788-9795. [PubMed] [Google Scholar]
  10. McKhann G , Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ARDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology. 1984; 34: 939-944. [DOI] [PubMed] [Google Scholar]
  11. Richmond W : Preparation and properties of a cholesterol oxidase from nocardia sp and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 1973; 19(2): 1350-1356. [PubMed] [Google Scholar]
  12. Onaka LI : Lipids. In Anderson SC, Cockayne S (eds.): Clinical Chemistry Concepts and Applications. London: W.B. Saunders, 1993. [Google Scholar]
  13. Gowan MW , Artiss JD, Stranbergh DR, Zak B: A peroxidasecoupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983; 29(3): 538-542. [PubMed] [Google Scholar]
  14. Ellefson RD , Caraway WY: Lipids and lipoproteins. In Fundamentals of Clinical Chemistry. London: W.B. Saunders, 1976: 474-541. [Google Scholar]
  15. Miller SA , Dykes DD, Polesky HS: Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988; 16(3): 1215-1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kontula K , Aalto-Setala K, Kuusi T, et al.: Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: Convenient alternative to phenotyping by isoelectric focusing. Clin Chem. 1990; 36(12): 2087-2092. [PubMed] [Google Scholar]
  17. Utermann G , Pruin N, Stainmetz A: Polymorphism of apolipoprotein E. Pt III: Effect of a single polymorphic gene locus on the plasma lipid levels in man. Clin Genet. 1979; 15: 63-72. [PubMed] [Google Scholar]
  18. Lenzen HJ , Assman G, Buckwalsky R, Schulte H: Association of apolipoprotein E polymorphism, low density lipoprotein cholesterol, and coronary artery disease. Clin Chem. 1986; 32(5): 778-781. [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES